Indoco Remedies · NSE: INDOCO · BSE: 532612
Q1 FY24 results · Apr–Jun 2023
Indoco Remedies reported revenue from operations of ₹426.50 crore (up 4.5% from Q1 FY23) and net profit of ₹24.18 crore (down 37.3% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 426.50 | 408.22 | +4.5% | 428.16 | −0.4% |
| Other income | 0.41 | 1.13 | −63.7% | 0.50 | −18.0% |
| Total income | 426.91 | 409.35 | +4.3% | 428.66 | −0.4% |
| Profit before tax | 33.91 | 48.35 | −29.9% | 38.93 | −12.9% |
| Net profit for the period | 24.18 | 38.57 | −37.3% | 25.81 | −6.3% |
| Attributable to shareholders of the company | 24.39 | (0.98) | Turned profit | 25.81 | −5.5% |
| EPS, basic (₹) | 2.62 | 4.19 | −37.5% | 2.80 | −6.4% |
| Net margin (%) | 5.7 | 9.4 | 6.0 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 422.88 | 407.90 | +3.7% | 427.46 | −1.1% |
| Other income | 0.41 | 1.13 | −63.7% | 0.49 | −16.3% |
| Total income | 423.29 | 409.03 | +3.5% | 427.95 | −1.1% |
| Profit before tax | 35.67 | 48.20 | −26.0% | 38.33 | −6.9% |
| Net profit for the period | 25.94 | 38.47 | −32.6% | 25.37 | +2.2% |
| EPS, basic (₹) | 2.81 | 4.17 | −32.6% | 2.75 | +2.2% |
| Net margin (%) | 6.1 | 9.4 | 5.9 |
Consolidated
- Filed with BSE
- 25 Jul 2023, 13:17 IST
- Board meeting
- 25 Jul 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 25 Jul 2023, 13:17 IST
- Board meeting
- 25 Jul 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE